The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

NCT03790631 · clinicaltrials.gov ↗
COMPLETED
Status
771
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Geneva, Switzerland

Collaborators